NDC 63083-2128

Lyme Nosode Drops 2128

Lyme Nosode Drops

Lyme Nosode Drops 2128 is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Professional Complementary Health Formulas. The primary component is Angelica Archangelica Root; Angelica Pubescens Root; Arnica Montana Whole; Babesia Microti; Borrelia Burgdorferi; Bovine Type Ii Collagen (tracheal Cartilage); Causticum; Ehrlichia Chaffeensis; Gambir; Goldenseal; Latiglutenase; Latrodectus Mactans; Magnesium Phosphate, Dibasic Trihydrate; Manganese; Oxalic Acid; Phytolacca Americana Root; Potassium Chloride; Rickettsia Akari; Toxicodendron Pubescens Leaf; Treponemic Skin Canker Human; Yucca Filamentosa Whole.

Product ID63083-2128_39691d1b-5f78-4ed5-aadf-76c3937c3464
NDC63083-2128
Product TypeHuman Otc Drug
Proprietary NameLyme Nosode Drops 2128
Generic NameLyme Nosode Drops
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date1984-08-15
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameProfessional Complementary Health Formulas
Substance NameANGELICA ARCHANGELICA ROOT; ANGELICA PUBESCENS ROOT; ARNICA MONTANA WHOLE; BABESIA MICROTI; BORRELIA BURGDORFERI; BOVINE TYPE II COLLAGEN (TRACHEAL CARTILAGE); CAUSTICUM; EHRLICHIA CHAFFEENSIS; GAMBIR; GOLDENSEAL; LATIGLUTENASE; LATRODECTUS MACTANS; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE; OXALIC ACID; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; RICKETTSIA AKARI; TOXICODENDRON PUBESCENS LEAF; TREPONEMIC SKIN CANKER HUMAN; YUCCA FILAMENTOSA WHOLE
Active Ingredient Strength2 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
Pharm ClassesCalculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 63083-2128-2

59 mL in 1 BOTTLE, DROPPER (63083-2128-2)
Marketing Start Date1985-08-15
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.